You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

carrelizumab

Showing 1 - 5 of 5
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Squamous Cell Carcinoma Trial in Nanjing (Carrelizumab, Paclitaxel injection, Cisplatin)

Enrolling by invitation
  • Esophageal Squamous Cell Carcinoma
  • Carrelizumab
  • +3 more
  • Nanjing, China
    The First Affiliated Hospital of Nanjing Medical University
Sep 19, 2023

Cholangiocarcinoma Trial (Carrelizumab, Solfantinib)

Not yet recruiting
  • Cholangiocarcinoma
  • (no location specified)
Jan 16, 2023

Nasopharyngeal Carcinoma Trial in Guangzhou (QL1706, Carrelizumab, Gemcitabine)

Recruiting
  • Nasopharyngeal Carcinoma
  • Guangzhou, Guangzhou, China
    Sun Yat-sen University Cancer Center
Oct 21, 2022

Breast Tumor, Breast Cancer, Hormone Receptor Positive Tumor Trial in Shanghai (PIK3CA inhibitor, AKT inhibitor, Carrelizumab)

Recruiting
  • Breast Neoplasm
  • +4 more
  • PIK3CA inhibitor
  • +12 more
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Jan 2, 2023

Non Small Cell Lung Cancer Trial in Wuhan (Carrelizumab, Pemetrexed (Nonsquamous NSCLC) or Nab-paclitaxel(Squamous NSCLC),

Recruiting
  • Non Small Cell Lung Cancer
  • Carrelizumab
  • +3 more
  • Wuhan, China
    Wuhan Union Hospital
Aug 27, 2021